- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2008
- Public Summary Document (PSD) November 2008 PBAC Meeting - PDF
Cetuximab – November 2008
Cetuximab, solution for I.V. infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux®, November 2008
Last updated
24 March 2009
